{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode'])) Logout @endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
Back
Survey Questionnaire Form
  1. In your perception, what is the ratio of male vs female patients that visit you with heart diseases and/or diabetic? (Tick the appropriate box) *
    2. Tick

    Male 20 30 40 50 60 70 80
    Female 80 70 60 50 40 30 20
  2. In your opinion, do you consider the patient compliance of 80% and above to be considered a good indication of overall compliance? *

  3. Adherence defined as patients taking their medication > 80% of the time. Based on this definition, please indicate the percentage (%) of your patients you believe to be compliant when they take medications for statins

  4. Similarly, please indicate the percentage (%) of your patients you believe to be compliant when they take medications for anti-diabetic drugs

  5. Also, please mention the percentage (%) of your patients you believe to be compliant when they take medications for anti-hypertensive medications

  6. In your perception, which gender (Male or Female) of the patients have better compliance in medication? *

  7. In your opinion, which is the most limiting factor to patients in using the lipid lowering drug therapy ?*

  8. In your practice, what % of Diabetic or hypertensive patients takes statin therapy individually as risk factors? *

  9. According to you what are the reasons for patient’s Discontinuation of statin therapy on their own

  10. Do you feel, the population in clinical trials for primary prevention with statins closely resembles the real world practise? *

  11. Do you feel, the results of primary prevention trial with statins are exactly applicable in your own real world practise with ref to cost benefit ratio? *

  12. In primary prevention setting where risk factors are documented, do you see any age cut-off with respect to statin treatment? *

  13. Do you feel recent risk calculators rightly estimate the global CV risk? *

  14. What were the major reasons in patients whom you have discontinued statin therapy? *

  15. Do you believe risk estimation with CV risk calculators & treatment recommendations by the guidelines are in consistency with the sound cost-benefit analysis? *